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FIRST CLINICAL CASE REPORTFirst case of vanA-positive Enterococcus mundtii in human urinary tract
infection in IranM. Shariﬁ-Rad1, S. Shadanpour3, A. van Belkum4, A. Soltani5 and J. Shariﬁ-Rad2
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Microbiology, Faculty of Biological Science, Tehran North Branch, Islamic Azad University, Tehran, Iran, 4) bioMérieux SA, Unit Microbiology, R&D Microbiology, La
Balme Les Grottes, France and 5) Department of Genetics and Biotechnology, Osmania University, Hyderabad, IndiaAbstractWe cultured enterococci from urinary tract infections in Iranian hospitals. Seven different Enterococcus species (E. rafﬁnosus, E. durans, E. hirae,
E. avium, E. mundtii, E. faecium and E. faecalis) were found. Seven strains were vancomycin resistant, leading to an overall vancomycin resistance
rate of 3.9%. The enterococcal infection rate was high and vancomycin-resistant enterococci incidence low. We report the ﬁrst vanA-positive
E. mundtii urinary tract infections.
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E-mail: Javad.shariﬁrad@gmail.comEnterococci are members of the gastrointestinal ﬂora and
emerged in the 1970s as leading causes of multidrug-resistant
hospital acquired infections [1]. Enterococcal colonization
may result in asymptomatic bacteriuria but also in overt urinary
tract infection (UTI) [2]. Vancomycin-resistant enterococci
(VRE), the most important class of drug-resistant enterococci,
mainly belong to the species Enterococcus faecium and contain
vanA and/or vanB genes [3]. There are four additional vanco-
mycin resistance genes: vanC, vanD, vanE and vanG [4,5].
Detection of VRE is possible with culture or PCR [6]. We
investigated UTI-related VRE and their vanA and vanB content
from samples of East Iranian origin.
We obtained 177 isolates from 358 urine specimens of pa-
tients with UTI from two hospitals (Amir Al-Momenin and
Imam Khomeini) in Zabol, Iran (2013–2014). Diagnostics
included Gram staining, catalase production, pyrrolidonyl ary-
lamidase detection and growth on bile-esculin/6.5% NaClw Microbe and New Infect 2016; 11: 68–70
w Microbes and New Infections © 2016 The Authors. Published by Elsevier Ltd on behalf of
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p://dx.doi.org/10.1016/j.nmni.2016.02.005media. Vancomycin susceptibility testing included screening on
brain–heart infusion (BHI) agar (Difco, USA) containing 6 μg/
mL vancomycin (Sigma, Germany). Teicoplanin susceptibility
testing was performed using 30 μg teicoplanin disks on Mueller-
Hinton agar (Difco; Mast, UK). Minimum inhibitory concen-
trations (MICs) were determined by agar dilution on BHI agar
[7]. The MIC breakpoint for both vancomycin and teicoplanin
resistance was 32 μg/mL. Susceptibility to vancomycin (MIC
4 μg/mL) and to teicoplanin (MIC 8 μg/mL) was according
to the Clinical and Laboratory Standards Institute.
DNA was extracted according to Perez-Hernandez et al. [8]
and used for vanA and vanB PCR. All enterococci were PCR
assayed for vanA and vanB genes using previously described
primers and protocols [9]. Resistant Enterococcus spp. strains
E. faecalis E206 (vanA positive) and E. faecium E2781 (vanB
positive) were used as positive controls; Enterococcus faecalis
ATCC 29212 was used as negative control.
We identiﬁed seven different species of Enterococcus:
E. rafﬁnosus 3.3% (n = 6), E. durans 2.8% (n = 5), E. hirae 3.9%
(n = 7), E. avium 4.5% (n = 8), E. mundtii 10% (n = 18), E. faecium
27% (n = 48), and E. faecalis 48% (n = 85) (n = Table 1).
E. faecalis and E. faecium accounted for 75% of the isolates. Out
of 94 isolates from Amir Al-Momenin hospital, 4 (4.2%) wereEuropean Society of Clinical Microbiology and Infectious Diseases
nses/by-nc-nd/4.0/)
TABLE 2. Distribution and VRE species diversity in two
hospitals in Zabol, Iran
Hospital
No. of
isolates
VRE
species,
n (%)
No. of Enterococcus spp.
E.
rafﬁnosus
E.
faecium
E.
faecalis
E.
mundtii
TABLE 1. Frequency of enterococcal species in two hospitals in Zabol, Iran
Hospital
No. of Enterococcus spp.
E. rafﬁnosus E. durans E. hirae E. avium E. mundtii E. faecium E. faecalis Total
Amir Al-Momenin 6 4 1 6 12 26 46 94
Imam Khomeini 0 1 6 2 6 24 39 83
Total 6 5 7 8 18 48 85 177
NMNI Shariﬁ-Rad et al. vanA-positive E. mundtii in UTI 69resistant to vancomycin: E. rafﬁnosus (n = 1), E. faecalis (n = 2)
and E. mundtii (n = 1) (see Fig. 1). Imam Khomeini Hospital
showed an even lower resistance rate of 3.6% (n = 3), including
two E. rafﬁnosus and one E. faecium strains. The overall van-
comycin resistance rate in the two hospitals was 3.9% (Table 2).Amir
Al-Momenin
94 4 (4.2) 1 0 2 1
Imam
Khomeini
83 3 (3.6) 2 1 0 0
Total 177 7 (3.9) 3 1 2 1
VRE, vancomycin-resistant enterococci.
FIG. 1. Patterns of agarose gel electrophoresis showing PCR ampliﬁ-
cation products for vancomycin resistant enterococci (VRE) lanes 1: E.
faecalis; lane 2: E. mundtii. Lane M, DNA 100 basepair molecular size
marker; C+: positive control; C−: negative control.
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This is an open access artiAll strains resistant to vancomycin showed an MIC of
>512 μg/mL, while MICs obtained for teicoplanin resistant
strains varied. E. faecium showed the highest teicoplanin MIC
(98 μg/mL). E. faecalis (69 μg/mL), E. mundtii (60 μg/mL) and
E. rafﬁnosus (18 μg/mL) showed lower MICs.
Hospital-based VRE endemicity differs between countries,
within a country and between different cities or hospitals. Here
we show that the enterococcal UTI rate in two Iranian medical
centers was relatively high. The VRE incidence, however, was
not excessive. We show further evidence for the existence of
infectious vanA-positive E. mundtii in humans beyond the single
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